What are the stages of leukopoiesis (white blood cell production)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stages of Leukopoiesis (White Blood Cell Production)

Leukopoiesis is a structured, hierarchical process beginning with pluripotent hematopoietic stem cells in the bone marrow and progressing through multiple stages of proliferation, commitment, and differentiation to produce mature white blood cells in the circulation. 1, 2

Hierarchical Stages of Leukopoiesis

Stage 1: Pluripotent Hematopoietic Stem Cells

  • Dormant stem cells in G0 phase that maintain life-long, stable cell renewal capacity 1
  • Possess self-renewal capability and multipotential differentiation capacity 2
  • Entry into cell cycle is promoted by early-acting cytokines including interleukin-1, interleukin-6 (IL-6), and granulocyte colony-stimulating factor (G-CSF) 1
  • Located in bone marrow in close contact with stromal cells and extracellular matrix 3

Stage 2: Multipotent Progenitor Cells

  • Commitment to myeloid lineage occurs through stochastic (random) differentiation rather than predetermined pathways 1
  • Proliferation of early hematopoietic progenitors requires interleukin-3 (IL-3) 1
  • Cells progressively lose self-renewal ability as they differentiate 4
  • Common myeloid progenitors give rise to all white blood cell lineages 2

Stage 3: Committed Progenitor Cells

  • Intermediate progenitors supported by granulocyte/macrophage colony-stimulating factor (GM-CSF) 1
  • Cells become committed to specific lineages (granulocytic, monocytic, lymphocytic) 1
  • Once committed to individual lineages, subsequent maturation is supported by late-acting, lineage-specific factors 1

Stage 4: Myelopoiesis - All Stages of Maturation

  • In chronic myeloid leukemia, bone marrow shows proliferation of myelopoiesis in all stages of maturation with predominance of mature forms 4, 5
  • Granulocytic lineage maturation supported by G-CSF 1
  • Monocytic lineage maturation supported by macrophage colony-stimulating factor (M-CSF) 1
  • Normal progression includes myeloblasts → promyelocytes → myelocytes → metamyelocytes → band forms → mature granulocytes 4

Stage 5: Mature Circulating Leukocytes

  • Terminally differentiated cells including neutrophils, eosinophils, basophils, monocytes/macrophages, and lymphocytes 4
  • Billions of cells generated and replaced daily in steady-state hematopoiesis 4
  • Mature cells have specific markers and functions distinct from immature progenitors 4
  • Passage from bone marrow to bloodstream regulated by stromal endothelial cells 3

Regulatory Mechanisms

Cytokine Hierarchy

  • Early-acting factors (IL-1, IL-6, stem cell factor) act on pluripotent cells and immature progenitors 1, 3
  • Intermediate factors (IL-3, GM-CSF) support proliferation of committed progenitors 1, 3
  • Late-acting, lineage-specific factors (G-CSF, M-CSF) support terminal differentiation 1, 3

Microenvironmental Support

  • Stromal cells (fibroblasts, endothelial cells, adipocytes) produce colony-stimulating factors and extracellular matrix proteins 3
  • Extracellular matrix proteins bind CSFs and present them to specific receptors on progenitor cells 3
  • Bone marrow endothelial cells regulate passage of mature cells into circulation 3

Pathological Alterations

Emergency Myelopoiesis

  • Pathological conditions perturb steady-state supply, resulting in emergency myelopoiesis to eliminate threats from infection, tissue damage, or cancer 4
  • Bacterial lipopolysaccharides augment production of IL-1, tumor necrosis factor, and M-CSF during infection 1

Aberrant Leukopoiesis

  • Chronic inflammation, autoimmune diseases, and cancer cause sustained, aberrant myelopoiesis with accumulation of immature myeloid cells that deviate from standard differentiation pathways 4
  • These cells have pathologic activation programs different from mature myeloid cells 4
  • In CML, genetic instability drives transformation through accelerated and blast phases with increasing blast percentages 4, 6

Clinical Significance

Unlike erythropoiesis with its feedback regulator erythropoietin, no feedback mechanism for leukopoiesis has been identified 1. Leukocyte production in steady state is maintained at a genetically determined level, with augmentation occurring through cytokine-mediated responses to infection or inflammation rather than negative feedback control 1.

References

2
Research

Hematopoiesis.

Pharmacotherapy, 1992

4
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Guideline

Leukemia Diagnosis and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6
Guideline

Blast Crisis in Leukemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis and treatment for a patient with severe cytopenia, leukopenia, anemia, and 21% blasts?
What is the recommended follow-up for a 13-year-old with isolated leukopenia (White Blood Cell count of 3.1) and an otherwise normal Complete Blood Count (CBC)?
How should I manage a 2‑year‑old male with mild leukopenia, mild neutropenia, microcytic‑hypochromic iron‑deficiency anemia, and a normal absolute lymphocyte count?
What are the management recommendations for a patient with leukopenia (low White Blood Cell count) and neutropenia (low Absolute Neutrophil Count)?
What is the appropriate management and diagnosis for an 11-year-old male with leukopenia (WBC count of 3.1), an elevated Red Cell Distribution Width (RDW) of 15.7, an Absolute Neutrophil Count (ANC) of 1494, and an Absolute Lymphocyte Count (ALC) of 952, considering he has had a prior WBC count of 3.9?
What dose of glipizide is equivalent to 6 units of insulin?
What are the symptoms and treatment options for Tetralogy of Fallot (TOF) in an outpatient setting?
What is the cause and treatment for sudden tingling pain on the lateral side of the thigh and inability to rise the leg?
What is the next step for a patient with atrial fibrillation (AFib) controlled to sinus rhythm with bisoprolol (beta-blocker) 2.5 mg twice a day (BID), and should they take it indefinitely?
How can I manage worsening intracranial pressure when lying flat on my back?
What is the recommended anesthesia approach for a patient with Acute Chest Pain (ACP) undergoing Laparoscopic Assisted Vaginal Hysterectomy (LAVH)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question